Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27(Kip1) and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells

Clinical Cancer Research

Volumn 5, Issue 8, 1999, Pages 2171-2177

  Ye, Dingwei ^a   Mendelsohn, John ^a   Fan, Zhen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27;

ARTICLE; CANCER GROWTH; CANCER RECURRENCE; FEEDBACK SYSTEM; GROWTH STIMULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RECURRENCE RISK; TRANSCRIPTION REGULATION;

ANDROGEN ANTAGONISTS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLOHEXIMIDE; DIHYDROTESTOSTERONE; DOWN-REGULATION; DRUG SYNERGISM; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FLUTAMIDE; HUMANS; MALE; METRIBOLONE; MICROTUBULE-ASSOCIATED PROTEINS; PROSTATIC NEOPLASMS; PROTEIN SYNTHESIS INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ANDROGEN; TESTOSTERONE CONGENERS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032771584     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1997. CA Cancer J. Clin., 47: 5-27, 1997.
2. Catalona, W. J. Management of cancer of the prostate. N. Engl. J. Med., 331: 996-1004, 1994.
3. Tang, D. G., and Porter, A. T. Target to apoptosis: a hopeful weapon for prostate cancer. Prostate, 32: 284-293, 1997.
4. Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Hittmair, A., Zhang, J., Thurnher, M., Bartsch, G., and Klocker, H. Regulation of prostatic growth and function by peptide growth factors. Prostate, 28: 392-405, 1996.
5. Motta, M., Dondi, D., Moretti, R. M., Montagnani, M. M., Pimpinelli, F., Maggi, R., and Limonta, P. Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth. J. Steroid Biochem. Mol. Biol., 56: 107-111, 1996.
6. Dondi, D., Moretti, R. M., Marelli, M. M., Motta, M., and Limonta, P. Growth factors in steroid-responsive prostatic tumor cells. Steroids. 61: 222-225, 1996.
7. Sherwood, E. R., and Lee, C. Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate. World J. Urol., 13: 290-296, 1995.
8. Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., and Pollak, M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (Washington DC), 279: 563-566, 1998.
9. Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., and Klocker, H. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res., 54: 5474-5478, 1994.
10. Jacobs, S. C., Story, M. T., Sasse, J., and Lawson, R. K. Characterization of growth factors derived from the rat ventral prostate. J. Urol., 139: 1106-1110, 1988.
11. Gregory, H., Willshire, I. R., Kavanagh, J. P., Blacklock, N. J., Chowdury, S., and Richards, R. C. Urogastrone-epidermal growth factor concentrations in prostatic fluid of normal individuals and patients with benign prostatic hypertrophy. Clin. Sci., 70: 359-363, 1986.
12. Hiramatsu, M., Kashimata, M., Minami, N., Sato, A., and Murayama, M. Androgenic regulation of epidermal growth factor in the mouse ventral prostate. Biochem. Int., 17: 311-317, 1988.
13. Connolly, J. M., and Rose, D. P. Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate, 15: 177-186, 1989.
14. Connolly, J. M., and Rose, D. P. Production of epidermal growth factor and transforming growth factor-α by the androgen-responsive LNCaP human prostate cancer cell line. Prostate, 16: 209-218, 1990.
15. Liu, X. H., Wiley, H. S., and Meikle, A. W. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-α (TGF-α) and epidermal growth factor (EGF)/TGF-α receptor. J. Clin. Endocrinol. Metab., 77: 1472-1478, 1993.
16. Scher, H. I., Sarkis, A., Reuter, V., Cohen, D., Netto, G., Petrylak, D., Lianes, P., Fuks, Z., Mendelsohn, J., and Cordon-Cardo, C. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor a in the progression of prostatic neoplasms. Clin. Cancer Res., 1: 545-550, 1995.
17. Gioeli, D., Mandell, J. W., Petroni, G. R., Frierson, H. J., and Weber, M. J. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res., 59: 279-284, 1999.
18. Navone, N. M., Olive, M., Ozen, M., Davis, R., Troncoso, P., Tu, S. M., Johnston, D., Pollack, A., Pathak, S., von Eschenbach, A. C., and Logothetis, C. J. Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin. Cancer Res., 3: 2493-2500, 1997.
19. KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody. Oncogene, 12: 1397-1403, 1996.
20. Morgan, D. O. Principles of CDK regulation. Nature (Lond.), 374: 131-134, 1995.
21. KIP1 and induces G1 arrest in prostatic cancer cell line DU145. Cancer Res., 56: 3666-3669, 1996.
22. Lu, S., Tsai, S. Y., and Tsai, M. J. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CK1 p16 genes. Cancer Res., 57: 4511-4516, 1997.
23. Perry, J. E., Grossmann, M. E., and Tindall, D. J. Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line. Prostate, 35: 117-124, 1998.
24. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85: 707-720, 1996.
25. Kip1-deficient mice. Cell, 85: 733-744, 1996.
26. Kip1. Cell, 85: 721-732, 1996.
27. Yang, R. M., Naitoh, J., Murphy, M., Wang, H. J., Phillipson, J., deKernion, J. B., Loda, M., and Reiter, R. E. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol., 159: 941-945, 1998.
28. KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J. Natl. Cancer Inst., 90: 1284-1291, 1998.
29. Kip1 in prostatic adenocarcinoma. Mod. Pathol., 11: 324-328, 1998.
30. Kip1 protein in human prostate cancer correlates with tumor grade. Clin. Cancer Res., 3: 2269-2274, 1997.
31. Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res., 58: 542-548, 1998.
32. Kip1 acts as a downstream effector of and is coexpressed with the β1C integrin in prostatic adenocarcinoma. J. Clin. Invest., 103: 321-329, 1999.
33. Kip1 in normal, hyperplastic, and neoplastic cells. Am. J. Pathol., 153: 911-919, 1998.
34. KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J. Natl. Cancer Inst., 91: 91, 1999.
35. Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J. Natl. Cancer Inst., 90: 916-920, 1998.
36. Traish, A. M., and Wotiz, H. H. Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrinology, 121: 1461-1467, 1987.
37. Schuurmans, A. L., Bolt, J., Veldscholte, J., and Mulder, E. Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J. Steroid Biochem. Mol. Biol., 40: 193-197, 1991.
38. Brass, A. L., Barnard, J., Patai, B. L., Salvi, D., and Rukstalis, D. B. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor. Cancer Res., 55: 3197-3203, 1995.
39. Goldstein, N. I., Prewett, M., Zuklys, K., Rockwell, P., and Mendelsohn, J. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin. Cancer Res., 1: 1311-1318, 1995.
40. Labrie, F. Mechanism of action and pure antiandrogenic properties of flutamide. Cancer (Phila.), 72: 3816-3827, 1993.
41. Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B.. Henner, D., Wong, W. L., Rowland, A. M., Kotts, C., Carver, M. E., and Shepard, H. M. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA, 89: 4285-4289, 1992.